Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novofarm-Biosintez is a Ukrainian pharmaceutical company established in 1996 and headquartered in Zviahel, Zhytomyr Oblast. The company specializes in the development, manufacturing, and quality testing of sterile infusion solutions, injection solutions, and anesthetics. Operating under Good Manufacturing Practice (GMP) standards, Novofarm-Biosintez produces a wide range of generic medicines, including sodium chloride, Ringer's solution, levofloxacin, propofol, and atracurium. Its products are widely used in emergency medical care, anesthesia, and the treatment of infectious and cardiovascular diseases. The company serves both the domestic Ukrainian market and export markets such as Azerbaijan and Moldova.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novofarm-Biosintez.